SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-061249
Filing Date
2024-05-16
Accepted
2024-05-16 18:15:29
Documents
2
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1565
2 EX-24 rna-ex24.htm EX-24 14375
  Complete submission text file 0000950170-24-061249.txt   17640
Mailing Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121
Business Address 10578 SCIENCE CENTER DRIVE SUITE 125 SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Issuer) CIK: 0001599901 (see all company filings)

IRS No.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVIDITY BIOSCIENCES, INC. 10578 SCIENCE CENTER DRIVE, SUITE 125 SAN DIEGO CA 92121
Business Address
Skerjanec Simona (Reporting) CIK: 0002022163 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39321 | Film No.: 24957160